Scholarlink

Bexarotene is a third-generation synthetic retinoid approved for the treatment of advanced stage cutaneous T cell lymphoma in adults refractory to at least one systemic treatment. However, it needs to be used with caution due to its side effect profile.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bexarotene

  • 章节

  • 发表日期：

    2025年

查看全文
  • Aditya Kumar Bubna

摘要

Bexarotene is a third-generation synthetic retinoid approved for the treatment of advanced stage cutaneous T cell lymphoma in adults refractory to at least one systemic treatment. However, it needs to be used with caution due to its side effect profile.